Last KW - Search Results

1

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.

Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC, Golub TR. Shipp MA, et al. Among authors: last kw. Nat Med. 2002 Jan;8(1):68-74. doi: 10.1038/nm0102-68. Nat Med. 2002. PMID: 11786909 Clinical Trial.

2

Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large B-cell lymphoma.

Last K, Debarnardi S, Lister TA. Last K, et al. Methods Mol Med. 2005;115:15-63. doi: 10.1385/1-59259-936-2:015. Methods Mol Med. 2005. PMID: 15998962

3

Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma.

Last KW, Cornelius V, Delves T, Sieniawska C, Fitzgibbon J, Norton A, Amess J, Wilson A, Rohatiner AZ, Lister TA. Last KW, et al. J Clin Oncol. 2003 Jun 15;21(12):2335-41. doi: 10.1200/JCO.2003.06.145. J Clin Oncol. 2003. PMID: 12805335

4

The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours.

Last K, Maharaj L, Perry J, Strauss S, Fitzgibbon J, Lister TA, Joel S. Last K, et al. Ann Oncol. 2006 May;17(5):773-9. doi: 10.1093/annonc/mdl004. Epub 2006 Feb 9. Ann Oncol. 2006. PMID: 16469755 Free article.

5

Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.

Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD, Chan WC, Delabie J, Braziel RM, Campo E, Gascoyne RD, Jaffe ES, Muller-Hermelink K, Ott G, Calaminici M, Norton AJ, Goff LK, Fitzgibbon J, Staudt LM, Andrew Lister T. Davies AJ, et al. Among authors: last kw. Br J Haematol. 2007 Jan;136(2):286-93. doi: 10.1111/j.1365-2141.2006.06439.x. Br J Haematol. 2007. PMID: 17278262 Free PMC article.

6

Familial follicular lymphoma: a case report with molecular analysis.

Last KW, Goff LK, Summers KE, Neat M, Jenner M, Crawley C, Rohatiner AZ, Fitzgibbon J, Lister TA. Last KW, et al. Br J Haematol. 2000 Sep;110(3):744-5. doi: 10.1046/j.1365-2141.2000.02239-2.x. Br J Haematol. 2000. PMID: 10997990 Free article. No abstract available.

7

Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL).

Sirohi B, Cunningham D, Norman A, Last K, Chau I, Horwich A, Oates J, Chong G, Wotherspoon A. Sirohi B, et al. Hematology. 2007 Apr;12(2):149-53. doi: 10.1080/10245330701214095. Hematology. 2007. PMID: 17454196

8

Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial.

Hall PS, Swinson D, Cairns DA, Waters JS, Petty R, Allmark C, Ruddock S, Falk S, Wadsley J, Roy R, Tillett T, Nicoll J, Cummins S, Mano J, Grumett S, Stokes Z, Kamposioras KV, Chatterjee A, Garcia A, Waddell T, Guptal K, Maisey N, Khan M, Dent J, Lord S, Crossley A, Katona E, Marshall H, Grabsch HI, Velikova G, Ow PL, Handforth C, Howard H, Seymour MT; GO2 Trial Investigators. Hall PS, et al. JAMA Oncol. 2021 Jun 1;7(6):869-877. doi: 10.1001/jamaoncol.2021.0848. JAMA Oncol. 2021. PMID: 33983395 Free PMC article. Clinical Trial.

9

Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients.

O'Brien ME, Borthwick A, Rigg A, Leary A, Assersohn L, Last K, Tan S, Milan S, Tait D, Smith IE. O'Brien ME, et al. Br J Cancer. 2006 Dec 18;95(12):1632-6. doi: 10.1038/sj.bjc.6603498. Br J Cancer. 2006. PMID: 17160081 Free PMC article.

10

A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO).

Hall PS, Lord SR, Collinson M, Marshall H, Jones M, Lowe C, Howard H, Swinson D, Velikova G, Anthoney A, Roy R, Dent J, Cheeseman S, Last K, Seymour MT. Hall PS, et al. Br J Cancer. 2017 Feb 14;116(4):472-478. doi: 10.1038/bjc.2016.442. Epub 2017 Jan 17. Br J Cancer. 2017. PMID: 28095397 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page